ArticleNature biotechnology2026
An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides.
Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Simultaneous characterization of proteins, RNAs and glycans with a nanopore remains a substantial challenge. To advance toward this goal, we introduce a multifunctional adaptor, maleimido-C2-formylphenylboronic acid (maleimido-C2-FPBA), into the Mycobacterium smegmatis porin A (MspA) nanopore at the pore constriction site. Here we demonstrate that the engineered nanopore, MspA-FPBA, enables the simultaneous identification of a diverse set of analytes, including 21 proteinogenic amino acids, three post-translationally modified (PTM) amino acids, four canonical nucleoside monophosphates (NMPs), three epigenetically modified NMPs, four monosaccharides and five peptides. Combined with machine learning, this sensor achieves an overall accuracy of 98.7%. Furthermore, it generates predictable event signatures for specific analyte types, enabling the machine learning model to identify analytes without strictly relying on prearchived event features, as demonstrated by the nanopore analysis of yeast cell extract. Lastly, we apply MspA-FPBA for compositional analysis of G2 glycopeptides. Future integration of hydrolase with MspA-FPBA may further improve MspA-FPBA utility as a single system to identify diverse biomolecules.
Identifiers
42736414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.